Javascript must be enabled to continue!
Identification of deactivation procedure for Trilaciclib
View through CrossRef
The Indian health-care facilities (HCFs) made some guidelines related to cytotoxic drugs so called cytotoxic policy for patient safety and health-care worker safety, and environmental monitoring program as per the available international guidelines. Trilaciclib is indicated for the treatment of patients with multiple myeloma and chemically it is a tetra peptide epoxy ketone and an analog of epoxomicin. Analytical method for the detection of Deactivating agent and concentration play an impartment role in the pharmaceuticals especially with cytotoxic molecules after completion of manufacturing and testing is mandatory to follow the safety protocol to dispose those materials. The present invention provides to identify the suitable deactivating agent for the neutralization of Trilaciclib injection 10 mg/mL and Trilaciclib API with respect to concentration and time. This method developed based by RP-HPLC.
Title: Identification of deactivation procedure for Trilaciclib
Description:
The Indian health-care facilities (HCFs) made some guidelines related to cytotoxic drugs so called cytotoxic policy for patient safety and health-care worker safety, and environmental monitoring program as per the available international guidelines.
Trilaciclib is indicated for the treatment of patients with multiple myeloma and chemically it is a tetra peptide epoxy ketone and an analog of epoxomicin.
Analytical method for the detection of Deactivating agent and concentration play an impartment role in the pharmaceuticals especially with cytotoxic molecules after completion of manufacturing and testing is mandatory to follow the safety protocol to dispose those materials.
The present invention provides to identify the suitable deactivating agent for the neutralization of Trilaciclib injection 10 mg/mL and Trilaciclib API with respect to concentration and time.
This method developed based by RP-HPLC.
Related Results
Secondary Trigger Point Deactivation Surgery for Nerve Compression Headaches: A Scoping Review
Secondary Trigger Point Deactivation Surgery for Nerve Compression Headaches: A Scoping Review
Background:
Primary trigger point deactivation surgery has been successful in reducing or eliminating nerve compression headaches between 79% and 90% of the time. The a...
Combustion and Exhaust Emission Improvement in a 3-Cylinder Mpfi Engine Through Downsizing
Combustion and Exhaust Emission Improvement in a 3-Cylinder Mpfi Engine Through Downsizing
This research aims to compare the potential and existing conditions of a small-sized spark ignition (SI) engine with a 1.0-liter capacity suitable for cylinder deactivation. The cy...
Mitigating Green Oil Deactivation in Acetylene Hydrogenation Using Carbon‐Supported Pd Catalysts
Mitigating Green Oil Deactivation in Acetylene Hydrogenation Using Carbon‐Supported Pd Catalysts
This study investigates the mitigation of green oil deactivation in acetylene hydrogenation using carbon‐supported Pd catalysts. Various carbon supports including CMK‐3, short CMK‐...
Abstract P72: Pattern of Deactivation of Implantable Cardioverter Defibrillator in Inpatient Hospice Units
Abstract P72: Pattern of Deactivation of Implantable Cardioverter Defibrillator in Inpatient Hospice Units
Background:
There have been an increasing number of patients receiving implantable cardioverter defibrillators (ICDs) over the last decade. Although ICDs prevent arrhyt...
Synthesis and Acetylcholinesterase Inhibitory Activity of Novel Trilaciclib Analogs
Synthesis and Acetylcholinesterase Inhibitory Activity of Novel Trilaciclib Analogs
AbstractTrilaciclib is a CDK4/6 inhibitor, used to treat the bone marrow damage in chemotherapy patients. A series of thirteen novel structural trilaciclib analogs was obtained to ...
STUDIES OF SYSTEM II PHOTOCENTERS BY COMPARATIVE MEASUREMENTS OF LUMINESCENCE, FLUORESCENCE, AND OXYGEN EMISSION*
STUDIES OF SYSTEM II PHOTOCENTERS BY COMPARATIVE MEASUREMENTS OF LUMINESCENCE, FLUORESCENCE, AND OXYGEN EMISSION*
Abstract— New results are presented on the emission of oxygen by algae and chloroplasts illuminated by a sequence of short saturating flashes. These results favor the four‐state hy...
Temporal And Spatial Changes In Cerebral Blood Flow In Neuropsychiatric Systemic Lupus Erythematosus: A Subtraction Brain Spect Study.
Temporal And Spatial Changes In Cerebral Blood Flow In Neuropsychiatric Systemic Lupus Erythematosus: A Subtraction Brain Spect Study.
Abstract
This study was addressed to evaluate the temporal and spatial changes in regional cerebral blood flow (rCBF) of patients with neuropsychiatric systemic lupus eryth...
Catalyst Deactivation/Regeneration
Catalyst Deactivation/Regeneration
AbstractThis article focuses on the causes, mechanisms, prevention, modeling, and treatment (experimental and theoretical) of deactivation. The causes of deactivation are basically...

